PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control.
Lorea Valcarcel-JimenezAlice MacchiaEva Crosas-MolistAriane Schaub-CleriguéLaura CamachoNatalia Martín-MartínPaolo CicognaCristina Viera-BardónSonia Fernández-RuizIrene Rodriguez-HernandezIvana HermanovaIanire AstobizaAna R CortazarJon Corres-MendizabalAntonio Gomez-MuñozVictoria Sanz-MorenoVeronica TorranoArkaitz CarracedoPublished in: Cancer research (2019)
The PPARγ coactivator 1 alpha (PGC1α) is a prostate tumor suppressor that controls the balance between anabolism and catabolism. PGC1A downregulation in prostate cancer is causally associated with the development of metastasis. Here we show that the transcriptional complex formed by PGC1α and estrogen-related receptor 1 alpha (ERRα) controls the aggressive properties of prostate cancer cells. PGC1α expression significantly decreased migration and invasion of various prostate cancer cell lines. This phenotype was consistent with remarkable cytoskeletal remodeling and inhibition of integrin alpha 1 and beta 4 expression, both in vitro and in vivo. CRISPR/Cas9-based deletion of ERRα suppressed PGC1α regulation of cytoskeletal organization and invasiveness. Mechanistically, PGC1α expression decreased MYC levels and activity prior to inhibition of invasiveness. In addition, PGC1α and ERRα associated at the MYC promoter, supporting the inhibitory activity PGC1α. The inverse correlation between PGC1α-ERRα activity and MYC levels was corroborated in multiple prostate cancer datasets. Altogether, these results support that PGC1α-ERRα functions as a tumor-suppressive transcriptional complex through the regulation of metabolic and signaling events. SIGNIFICANCE: These findings describe how downregulation of the prostate tumor suppressor PGC1 drives invasiveness and migration of prostate cancer cells.
Keyphrases
- prostate cancer
- skeletal muscle
- transcription factor
- radical prostatectomy
- crispr cas
- poor prognosis
- gene expression
- insulin resistance
- cell proliferation
- signaling pathway
- dna methylation
- oxidative stress
- type diabetes
- binding protein
- genome editing
- benign prostatic hyperplasia
- adipose tissue
- metabolic syndrome
- fatty acid
- heat shock